The coronavirus disease 2019 (COVID-19) has led to a global health crisis. Its clinical manifestations are well-documented, and severe complications among patients who survived the infection are being continuously reported. Several vaccines with well-established efficacies and excellent safety profiles have also been approved. To date, few side effects of vaccines have been reported. Drug-induced hepatotoxicity is an extremely rare side effect of these vaccines, with few reported instances. In this case report, we describe a patient who experienced hepatotoxicity after receiving the COVID-19 vaccine from Pfizer BioNTech.

Ventriculo-peritoneal (VP) shunt is one of the most commonly used therapeutic methods for hydrocephalus. And the incidence across the world of VP shunt complications varies from 20% to 45%. One of the rare complications is the catheter perforation of the abdominal viscera and its extrusion through the anal cavity. For the first time in the literature, this report addresses the presentation of iatrogenic perforation of the colon while inserting the peritoneal catheter of VP shunt.Here, we present the case of a 15-year-old boy who is known to have cerebral palsy and congenital hydrocephalus with a VP shunt since birth. He presented to the ER with a history of headache and episodes of vomiting and was diagnosed with VP shunt dysfunction. The patient was taken for an emergency operation for shunt revision and a new shunt was placed. Then the next day he developed signs and symptoms of peritonitis with the distal part of the catheter protruding from the anal cavity, the patient was taken to the operating room for an exploratory laparotomy, the distal catheter was removed and replaced with external ventricular drainage, intra-operatively it was shown that the catheter was inserted directly into the colon causing bowel perforation, This report raises important questions about the nature of VP shunt bowel perforation and discusses management options.

There is an emerging body of literature describing an increasing incidence of pneumomediastinum and, to a lesser extent, pneumopericardium as a complication of COVID-19. However, the literature lacks information regarding patients' characteristics and a general view of this unusual condition. The purpose of this paper is to summarize the current literature on this phenomenon. In this study, we summarize the risk factors/etiology, imaging modalities, management, and prognosis of known cases in the literature. In total, 48 articles were included in the study, ranging from case reports to case series. Most patients were male (83.3%). The overall mortality rate was 27.1% and the recovery rate was 62.5%.

No abstract